BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Calendar//CN-US Event Research//ZH
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Calendar
X-WR-CALDESC:Market-moving event research, reminders and post-event review.
BEGIN:VEVENT
UID:evt-fda-pharmacy-compounding-adcom-peptides-july-2026@catalyst-calendar.local
DTSTAMP:20260720T200547Z
DTSTART:20260723T120000Z
DTEND:20260723T123000Z
SUMMARY:FDA药房复合咨询委员会审议多种肽类503A Bulks List窗口
DESCRIPTION:FDA Pharmacy Compounding Advisory Committee将于7月23日至24日审议BPC-157、KPV、TB-500、MOTs-C、Semax、Epitalon等肽类是否纳入503A Bulks List，可能影响肽类复合药房、远程医疗和GLP-1/代谢健康灰色市场监管预期。\\nImpact score: 68\\nExpected: 委员会建议和FDA后续立场可能影响复合药房可供给品类、远程医疗合规成本和代谢/抗衰老消费医疗叙事。\\nAffected: HIMS(theme\, mixed\, score 70)\; XBI(etf\, mixed\, score 62)\; LFMD(theme\, mixed\, score 58)\; LLY(peer\, mixed\, score 48)\; NVO(peer\, mixed\, score 48)\\nSources: FDA Advisory Committee Calendar: https://www.fda.gov/advisory-committees/advisory-committee-calendar\\nFDA PCAC July 23-24 2026 meeting page: https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026\\nFDA Meetings\, Conferences and Workshops: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops\\nFederal Register PCAC notice: https://www.federalregister.gov/documents/2026/04/16/2026-07361/pharmacy-compounding-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request\\nInformation only. Not investment advice.
URL:https://0.0.0.0:3000/?event=evt-fda-pharmacy-compounding-adcom-peptides-july-2026
CATEGORIES:fda\,US\,FDA\,PCAC\,compounding\,peptides\,telehealth\,advisory committee
SEQUENCE:0
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:Review catalyst preview: FDA药房复合咨询委员会审议多种肽类503A Bulks List窗口
END:VALARM
BEGIN:VALARM
TRIGGER:PT24H
ACTION:DISPLAY
DESCRIPTION:Complete post-event review: FDA药房复合咨询委员会审议多种肽类503A Bulks List窗口
END:VALARM
END:VEVENT
END:VCALENDAR